Opinion

A space for healthcare professionals to freely share and discuss their opinions and experiences. Please contact us if you’d like to contribute.

WHAT'S ON THE HORIZON?

Opinion & insight from our Clinical Steering Group

Horizons, led by a team of experts from our Clinical Steering Group, is a series of scientific articles which take a deep dive into the emerging trends in the healthcare landscape, kickstarting a dialogue about how treatments and strategies should be best implemented for the benefit of patients. Click below to find out more.

Looking to the horizon - Breakthrough drugs and treatments

Marshall Pearce

How close are we to a disease-modifying treatment for Alzheimer’s?

Posted 7 months ago

Alzheimer’s disease is a snowballing problem, one that is currently without a convincing solution. The progressive decline in cognitive function seen in patients with Alzheimer’s disease is associated strongly with plaques formed of amyloid beta in the brain, creating neurofibrillary tangles and leading to neuronal destruction. While some treatments improve cognition in the short-term, current therapeutic options are unable to modify or slow the disease process.

Penny Staton

Improving non-alcoholic steatohepatitis care – is the finishing line in sight?

Posted 9 months ago

An intense race is going on right now in non-alcoholic steatohepatitis (NASH) research. A number of significant players within the pharmaceutical and biotechnology sectors are competing to develop the first major therapeutic advance in treatment for this neglected condition. But should we consider it more of a relay race? Could improved diagnosis, disease assessment and even combination therapy be the key to victory over this increasingly prevalent disease?

Marshall Pearce

Left ventricular assist devices – A viable therapeutic option for heart failure?

Posted 1 year ago

Alongside a pharmacological strategy to aid myocardial recovery, LVADs may prove to have a significant role to play in the ever-growing problem of heart failure. Although LVADs are not new onto the scene, the advance of technology – smaller, more efficient devices with better reliability and potentially transcutaneous power transfer – means we may be on the cusp of seeing many more deployed to tackle heart failure.

Newest posts

EAACI hot topics: Hereditary angioedema (HAE)

For many the fear of the unknown is a daunting thought, but particularly so for patients with HAE. Left untreated, this disease causes unpredictable recurrent severe swelling, typically of the limbs, face, intestinal tract and airway.

Lauren McCracken

Lauren McCracken works for our sister agency Digital Medical Communications (DMC Ltd) as an

...

EULAR 2018 – Biosimilars: the future of rheumatology?

EULAR's Annual European Congress of Rheumatology aims to encourage innovation and collaboration across all aspects of rheumatology, something that is particularly well illustrated by biologics and their more affordable counterpart, biosimilars. Could they unlock the door to accessible, life-changing treatment for millions more?

Alex Keen

Alex studied Biological Sciences at university before joining EPG Health in January 2017, where

...

EAACI hot topics: Allergen specific immunotherapy (AIT)

When should AIT be used to treat your patients with allergies? Is it right for every allergy? And do we really know the long-term effects of this treatment? This blog highlights some of the talking points surrounding AIT discussed at this year’s EAACI Congress.

Lauren McCracken

Lauren McCracken works for our sister agency Digital Medical Communications (DMC Ltd) as an

...

EAACI 2018 ‒ Allergy management and the smart technology revolution

The theme of this year’s EAACI congress is ‘innovations for allergy’, so we started thinking what smart technologies, if any, are in development or on the market that could address the allergy epidemic?

Alex Keen

Alex studied Biological Sciences at university before joining EPG Health in January 2017, where

...

More posts

Liam Farrell

Bad smells are good

Posted 1 year ago

Delicacy is not a virtue in this job.

Am Ang Zhang

Autism: Challenges and Obstacles!

Posted 2 years ago

Retired child psychiatrist Am Ang Zhang discusses his experiences of working with the families of autistic children.

Am Ang Zhang

Autism: Frances Tustin and Entrenchment!

Posted 2 years ago

Am Ang Zhang discusses his work with pioneering child psychotherapist Frances Tustin, and his observations of entrenchment in autistic children.

Robin Hewings

Diabetes Patients Must Be Better Educated About Their Condition

Posted 2 years ago

Not everyone is convinced that education courses help people look after their diabetes. And the GP I was chatting to a couple of months ago was one of them. He wasn’t sure they worked. People didn’t seem that interested and he wasn’t really sure what people would learn anyway.

Alastair Miller

What is Tropical Medicine?

Posted 2 years ago

At first sight this seems a question with an obvious response and not one that requires much debate in this blog. However, the answer may be more complex than it initially appears and may benefit from further exploration.

Hugh Harvey

Metrics Madness

Posted 2 years ago

You shouldn't judge a book by its cover. That much is true, but it's also common sense not to judge a book by measuring the whiteness of its pages, or the amount of hamsters you can place on it. So why do we measure the fabulous NHS with nonsense metrics?

Edzard Ernst

But he knows nothing about homeopathy!

Posted 2 years ago

Whenever I criticise their methods, homeopaths claim that my arguments are invalid because I know next to nothing about the subject. Is this because they feel threatened by my arguments? Or could it be that the allegation is incorrect?

You can judge for yourself - here is a (slightly shortened and revised) excerpt from my recent memoire ‘A SCIENTIST IN WONDERLAND’ which recounts my exposure to and experience in homeopathy.

David Warriner

What is Overdiagnosis?

Posted 2 years ago

Overdiagnosis is the diagnosis of disease that will cause neither morbidity nor mortality during a patient’s lifetime. Doctors are trained to listen, examine, test, diagnose and treat patients, but we are not warned of the possible dangers of “diseases”, the diagnosis of which will not benefit the patient and may also lead to harm. I would argue that the Hippocratic oath, in particular “Primum non nocere” (first, do no harm) should be at the forefront of every clinician’s mind when seeing patients.

Opinion archive